Tag Archives: grants

No Facts for YOU!

The NIH funding argument is a broken record: Advocates and researchers say, “We want more funding!” NIH replies, “We need more applications!” And advocates and researchers reply, “Your review panel is made up of dentists!” Back and forth. Back and … Continue reading

Posted in Advocacy, Research | Tagged , , , , , , , , | 14 Comments

Drug and FDA News, May 2013

Yesterday, the CFIDS Association formally announced what had been rumored to be on the way: they are preparing to file an Investigational New Drug application. The first step will be a pre-IND meeting with FDA. This kind of meeting is … Continue reading

Posted in Research | Tagged , , , , , , , | 4 Comments

CFSAC Testimony May 2013

I submitted two versions of testimony to the May 22-23, 2013 CFS Advisory Committee meeting. My written testimony can be viewed here.  What follows is the testimony I delivered by telephone this morning: My name is Jennifer Spotila, and I … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , , , | 18 Comments

2012 NIH Spending on CFS Studies

Update: This post was revised on October 29, 2016 to correct mathematical errors and update the included research. NIH spending on ME/CFS research has been controversial since I’ve been in advocacy, largely because the funding numbers are so low compared … Continue reading

Posted in Research | Tagged , , , , , , , , , | 11 Comments

NIH Collaboration

The news didn’t make much of a splash, but NIH recently issued a funding opportunity announcement that could benefit people with CFS. This purpose of this funding opportunity is to support “collaborative translational research projects” aimed at turning basic discoveries … Continue reading

Posted in Research | Tagged , , , , , , , , | Comments Off on NIH Collaboration

Another CFSAC Done Gone

The CFS Advisory Committee held its second meeting of the year on October 3-4, 2012. Last time, I organized my summary around the good, the bad, and the WTF moments. This time, I am organizing around the discussion themes. Overall, … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , , , , , , , , , , | 16 Comments

Metrics

I delivered the following testimony via telephone to the CFS Advisory Committee on October 3, 2012. I would like to note something that Dr. Nancy Lee said today: “Nothing about me without me.” That’s what we’re asking for. FDA is … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , , | 6 Comments

Those Lipkin Samples

You may recall from my post on the Lipkin study that Dr. Lipkin talked about the sample cohort at the press conference on September 18th. Dr. Lipkin said that the samples would be available for other investigators and that applications … Continue reading

Posted in Research | Tagged , , , , , , , , , , , | 4 Comments

2011 NIH Spending on CFS Studies

At the June 2012 CFS Advisory Committee meeting, Dr. Susan Maier from the NIH Office of Research on Women’s Health reported that NIH funding of CFS research in 2011 totaled $6.3 million. In the past, advocates have questioned whether studies … Continue reading

Posted in Research | Tagged , , , , , , , , , , , , , | 3 Comments

Virtually Reality

Today, the CFIDS Association announces its latest research grants and projects. I know many of us want to dive into the details of the grants, but I want to first take a look at the big picture. The Association describes … Continue reading

Posted in Research | Tagged , , , , , , , , , | 4 Comments